TY - JOUR
T1 - Corrigendum to “HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome” [Eur J Cancer 211 (2024) 114307] (European Journal of Cancer (2024) 211, (S0959804924009638), (10.1016/j.ejca.2024.114307))
AU - Bottosso, Michele
AU - Sandoval, Renata L.
AU - Verret, Benjamin
AU - Polidorio, Natalia
AU - Caron, Olivier
AU - Gennari, Alessandra
AU - Bychkovsky, Brittany L.
AU - Cahill, Sophie H.
AU - Achatz, Maria I.
AU - Guarneri, Valentina
AU - André, Fabrice
AU - Garber, Judy E.
N1 - Publisher Copyright:
© 2025 Elsevier Ltd
PY - 2025/1/1
Y1 - 2025/1/1
N2 - The authors regret that correction to the institution detail is required and would like to add an additional affiliation for Dr Michele Bottosso and Professor Valentina Guarneri, in order to accurately reflect their institutional affiliations. The affiliation to be added should be: • Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy. The authors would like to apologise for any inconvenience caused." DOI of original article: https://doi.org/10.1016/j.ejca.2024.114307
AB - The authors regret that correction to the institution detail is required and would like to add an additional affiliation for Dr Michele Bottosso and Professor Valentina Guarneri, in order to accurately reflect their institutional affiliations. The affiliation to be added should be: • Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy. The authors would like to apologise for any inconvenience caused." DOI of original article: https://doi.org/10.1016/j.ejca.2024.114307
UR - http://www.scopus.com/inward/record.url?scp=105000248942&partnerID=8YFLogxK
U2 - 10.1016/j.ejca.2025.115370
DO - 10.1016/j.ejca.2025.115370
M3 - Comment/debate
AN - SCOPUS:105000248942
SN - 0959-8049
JO - European Journal of Cancer
JF - European Journal of Cancer
M1 - 115370
ER -